Abstract
Acute respiratory viral infections (ARVI) are widespread diseases caused by numerous pneumotrophic viruses.They are treated with antiviral drugs of direct action, interferons and inducers of interferons.The inducers of interferons of the group of natural compounds include the modern Russian antiviral drug Kagocel ® .The safety evaluation of Kagocel ® was carried out in preclinical studies on laboratory animals, and the therapeutic efficacy and safety in the treatment of patients with ARVI was proved by the results of numerous clinical and post approval studies.Keywords: acute respiratory viral infections, treatment, interferon inducers, Kagocel ® .For reference: Kassenova SL.Interferon inductors in the treatment of acute respiratory viral infections.Meditsina